Xenon inhibits but N2O enhances ketamine-induced c-Fos expression in the rat posterior cingulate and retrosplenial cortices

Anesthesia and Analgesia

Volumn 92, Issue 2, 2001, Pages 362-368

  Nagata, Atsushi ^a   Nakao, Shin Ichi ^a   Nishizawa, Nobuyasu ^a   Masuzawa, Munehiro ^a   Inada, Takefumi ^a   Murao, Kohei ^a   Miyamoto, Etsuko ^a   Shingu, Koh ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

KETAMINE; MICROTUBULE ASSOCIATED PROTEIN 2; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NITROUS OXIDE; XENON;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN REGION; CINGULATE GYRUS; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; DRUG SAFETY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0035143412     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/00000539-200102000-00016     Document Type: Article

References (30)

1. The anesthetic properties of xenon in animals and human beings, with additional observations on krypton
2. Observation on the anesthetic effect of the combination of xenon and halothane
3. Solubility coefficient for inhaled anaesthetics for water, oil and biological media
4. Xenon provides faster emergence from anesthesia than does nitrous oxide-sevoflurane or nitrous oxide-isoflurane
5. Anaesthesia and the 'inert' gases with special reference to xenon
6. Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin
7. How does xenon produce anaesthesia?
8. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs
9. The behavioural effects of MK-801 in rats: Involvement of dopaminergic, serotonergic and noradrenergic systems
10. NMDA antagonist neurotoxicity: Mechanism and prevention
11. Ketamine acts as a non-competitive N-methyl-D-aspartate antagonist on frog spinal cord in vitro
12. Phencyclidine-induced expression of c-Fos like immunoreactivity in mouse brain regions
13. The effects of ketamine isomers on the mice behavior and c-Fos expression in the posterior cingulate cortex
14. Induction and suppression of immediate early genes in specific rat brain regions by the non-competitive N-methyl-D-aspartate receptor antagonist MK-801
15. Effects of phencyclidine on immediate early gene expression in the brain
16. Direct measurement of nitrous oxide MAC and neurologic monitoring in rat during anesthesia under hyperbaric conditions
17. The minimum alveolar concentration of nitrous oxide in man
18. Halothane and diazepam inhibit ketamine-induced c-fos expression in the rat cingulate cortex
19. The c-Fos complex and Fos-related antigens recognize sequence elements that contain AP-1 binding sites
20. The use of c-fos as a metabolic marker in neuronal pathway tracing
21. C-fos antisense in the nucleus accumbens block the locomotor stimulant action of cocaine
22. Infusion into brain of an antisense oligonucleotide to the immediate-early gene c-fos suppresses production of Fos and produces a behavioral effect
23. Microtubule-associated proteins: Their potential role in determining neuronal morphology
24. Microtubule-associated protein 2 as a sensitive marker for cerebral ischemic damage-immunohistochemical investigation of dendritic damage
25. Effects of neopterin on ischemic neuronal damage in gerbils
26. The neuronal cytoskeleton is at risk after mild and moderate brain injury
27. Haloperidol prevents induction of the hsp70 heat shock gene in neurons injured by phencyclidine (PCP), MK801, and ketamine
28. High-dose ketamine does not induce c-Fos protein expression in rat hippocampus
29. Propofol inhibits ketamine-induced c-fos expression in the rat posterior cingulate cortex
30. A activation is involved in the inhibitory effect of propofol on ketamine-induced c-Fos expression in the rats posterior cingulate cortex